ESMO Congress 2026 opened in Madrid: spotlight on optimising cancer care?
esmo - The ESMO Congress 2026 opened today in Madrid, over 40,000 attendees expected, more than 6,300 abstracts submitted and around 230 sessions.
AI Summary: The ESMO 2026 Congress kicked off in Madrid with a clear agenda: optimise cancer care across settings. Speakers emphasised translating trial data into practice, tackling health inequities, and refining biomarker‑driven strategies. Expect spirited debates, high‑stakes late‑breaking results, and the usual congress hustle of science, networking and slightly overcaffeinated poster sessions.
- Colorectal cancer: targeted strategies and immunotherapy results (3)
- ESMO26 Opening: themes, collaboration and future data (4)
- Genitourinary oncology: bladder, MIBC and prostate updates (4)
- Gynecologic cancers: endometrial and cervical immunotherapy trials (4)
Colorectal cancer: targeted strategies and immunotherapy results
ESMO26 Opening: themes, collaboration and future data
Genitourinary oncology: bladder, MIBC and prostate updates
Gynecologic cancers: endometrial and cervical immunotherapy trials
Related Stories
ELCC 2026 showcases lung-cancer trials, new data, and collaborations / 6 months
AACR launches Rare Cancers Initiative to accelerate research collaboration / 2 months
AstraZeneca deal to bring sunvozertinib to US expands access for EGFR Exon20 patients / 3 months
DESTINY‑Lung03: T‑DXd shows activity in HER2 lung cancer; triplet stalls / 4 months
Perioperative advances reshape muscle‑invasive bladder cancer care / 2 months
ALTAIR trial probes ctDNA‑guided post‑adjuvant therapy in CRC / 4 months
Perioperative apalutamide plus ADT improves high‑risk prostate outcomes / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Animal Health, Diagnostics, None, Trump Administration and look for the RSS link.
StackHealth Time Machine